Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.

The effect of carotid endarterectomy (CEA) and carotid artery stenting (CAS) on visual function has not been a specific end-point of most trials comparing CAS and CEA. Ischaemic lesions of the retina and optic nerve have been reported to occur in 15-46% of carotid patients, while carotid artery sten...

Full description

Bibliographic Details
Main Authors: Giannoukas, A, Paraskevas, K, Bulbulia, R, Halliday, A
Format: Journal article
Language:English
Published: Elsevier 2014
_version_ 1797074431220121600
author Giannoukas, A
Paraskevas, K
Bulbulia, R
Halliday, A
author_facet Giannoukas, A
Paraskevas, K
Bulbulia, R
Halliday, A
author_sort Giannoukas, A
collection OXFORD
description The effect of carotid endarterectomy (CEA) and carotid artery stenting (CAS) on visual function has not been a specific end-point of most trials comparing CAS and CEA. Ischaemic lesions of the retina and optic nerve have been reported to occur in 15-46% of carotid patients, while carotid artery stenosis significantly reduces blood flow to the eye and orbit, resulting in the ocular ischaemic syndrome.
first_indexed 2024-03-06T23:36:03Z
format Journal article
id oxford-uuid:6db1cfe2-3bb3-4de9-8758-dae92ea6d0bd
institution University of Oxford
language English
last_indexed 2024-03-06T23:36:03Z
publishDate 2014
publisher Elsevier
record_format dspace
spelling oxford-uuid:6db1cfe2-3bb3-4de9-8758-dae92ea6d0bd2022-03-26T19:19:25ZOcular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6db1cfe2-3bb3-4de9-8758-dae92ea6d0bdEnglishSymplectic Elements at OxfordElsevier2014Giannoukas, AParaskevas, KBulbulia, RHalliday, AThe effect of carotid endarterectomy (CEA) and carotid artery stenting (CAS) on visual function has not been a specific end-point of most trials comparing CAS and CEA. Ischaemic lesions of the retina and optic nerve have been reported to occur in 15-46% of carotid patients, while carotid artery stenosis significantly reduces blood flow to the eye and orbit, resulting in the ocular ischaemic syndrome.
spellingShingle Giannoukas, A
Paraskevas, K
Bulbulia, R
Halliday, A
Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
title Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
title_full Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
title_fullStr Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
title_full_unstemmed Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
title_short Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
title_sort ocular defects as surrogate end points in trials comparing carotid endarterectomy and stenting
work_keys_str_mv AT giannoukasa oculardefectsassurrogateendpointsintrialscomparingcarotidendarterectomyandstenting
AT paraskevask oculardefectsassurrogateendpointsintrialscomparingcarotidendarterectomyandstenting
AT bulbuliar oculardefectsassurrogateendpointsintrialscomparingcarotidendarterectomyandstenting
AT hallidaya oculardefectsassurrogateendpointsintrialscomparingcarotidendarterectomyandstenting